NCT04301804View on ClinicalTrials.gov

A Trial of SHR6390 in Healthy Caucasian Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 12, 2020

Primary Completion Date

May 28, 2020

Study Completion Date

September 28, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

SHR6390

a selective small-molecule CDK4/6 inhibitor

Trial Locations (1)

Unknown

Linear Clinical Research, Melbourne

All Listed Sponsors
lead

Atridia Pty Ltd.

INDUSTRY

NCT04301804 - A Trial of SHR6390 in Healthy Caucasian Volunteers | Biotech Hunter | Biotech Hunter